Navigation Links
AccuVein Receives Grant for its Award Winning AV300 Vein Illumination System
Date:11/4/2010

COLD SPRING HARBOR, N.Y., Nov. 4, 2010 /PRNewswire/ -- AccuVein LLC, the developer of the first non-contact, handheld vein illumination system, announced today that it had been awarded the maximum grant amount from the Qualifying Therapeutic Discover Project (QTDP) program.  This Federal grant program supports projects that show significant potential to produce new therapies, address unmet medical needs, and reduce the long-term growth of health care costs.

AccuVein's AV300 helps health care professionals locate veins for blood draw, IV infusion and blood donation by projecting a pattern of light on patient's skin that reveals the position of underlying veins.  This 10-ounce, hand-held device is available with a range of hands-free options so that it can quickly free the practitioner's hands to perform the venipuncture.  It is the first and only system of its kind.

"Hospitals are adopting vein visualization as the standard-of-care for venipuncture as a tool to reduce error, reduce cost and increase patient satisfaction," said AccuVein engineering vice president Joe Zott.  "Winning this grant will support our continued investment in delivering the best vein illumination system in the market."

About AccuVein

AccuVein LLC is a supplier of innovative, cutting-edge medical devices. The award winning AV300 allows health care providers to see a map of the position of peripheral veins on the skin's surface with the goal of helping to improve venipuncture procedures. Built using AccuVein's expertise in medical device miniaturization and user-intuitive design, the AV300 is the world's first portable, non-contact vein illumination solution. The AccuVein AV300 was the recipient of the 2010 Medical Design Excellence Award and was cited as a 2009 best new product in Contemporary Pediatrics Magazine.   AccuVein has filed applications for more than a dozen patents on the AV300's technology. It is in use at more than 400 U.S. hospitals and available for sale in over 50 countries. For more information on AccuVein's AV300, please visit www.accuvein.com.


'/>"/>
SOURCE AccuVein
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Fenwal Named Exclusive Provider of AccuVeins Award-Winning Vein Illumination Device for Blood and Plasma Centers
2. AccuVein Signs Exclusive Distribution Agreement in India to Sell Vein Illumination Device
3. AccuVein AV300 Named a Best New Product by Contemporary Pediatrics
4. AccuVein Signs Multiple-Country Distribution Agreement in Europe for Vein Illumination Device
5. Cocrystal Discovery Receives Awards for Its Novel Antiviral Drug Development Programs
6. DNA Medicine Institute Receives Qualifying Therapeutic Discovery Grant
7. Cardiogenesis Receives Research Award From Federal Government
8. BioMedixs TRAKnet Practice Management Software Receives ONC-ATCB 2011/2012 Certification
9. Pfizers Lyrica® (Pregabalin) Capsules CV Receives Approval for Treatment of Peripheral Neuropathic Pain In Japan
10. Roche Receives FDA Approval for a Second-Generation Hepatitis C Viral Load Test
11. BD Ranks Among Top 25 U.S. Companies in Newsweeks 2010 Green Rankings; Receives EPA Green Power Leadership Award; Named to Dow Jones Sustainability World Index for Fifth Consecutive Year
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/30/2017)... 30, 2017  Akcea Therapeutics, a subsidiary of Ionis ... a Phase 2b dose-ranging study of AKCEA-APO(a)-L Rx ... goal of the study is to determine the dose ... in a planned Phase 3 cardiovascular outcome study. ... strategic collaboration with Novartis to develop and commercialize drugs ...
(Date:3/29/2017)... March 29, 2017  Bodycad announced today that ... (FDA) 510(k) clearance for its Bodycad Unicompartmental Knee ... personalized orthopaedic restoration. Bodycad is the first Canadian ... reconstruction implant system. Bodycad,s revolutionary ... restoration of the patient,s unique anatomical features and ...
(Date:3/29/2017)... , March 29, 2017 Avelas Biosciences, Inc., a ... diagnosis through treatment, today announced that Carmine N. Stengone , ... company at the Needham & Company 16 th Annual Healthcare ... a.m. PDT) at the Westin Grand Central Hotel in ... ...
Breaking Medicine Technology:
(Date:3/29/2017)... ... March 30, 2017 , ... Grass pollen is the main cause of hay fever ... stuff. The season for grass pollen runs from May to July each year; with the ... victim to do? HayMax™ allergen barrier balms ( http://www.haymax.us ) provide an effective defense against ...
(Date:3/29/2017)... ... 29, 2017 , ... Wells Pharmacy Network, a proud A4M ... upcoming World Congress, in Hollywood Florida April 6-8, 2017. , Ben David, CEO ... leader in the training of physicians, scientists, and members of the public on ...
(Date:3/29/2017)... , ... March 29, 2017 , ... Dr. Angela Cotey, ... orthodontic treatment and accepting new pediatric patients, with or without a referral. Dr. Cotey ... have a better orthodontic outcome and experience. When patients receive early treatment, they may ...
(Date:3/29/2017)... ... March 29, 2017 , ... An ... braces. "The rubber bands used in conjunction with my braces always rubbed against ... design a way to prevent this problem." The O.B.S. was the result of ...
(Date:3/29/2017)... ... March 29, 2017 , ... ... South Hills of Pittsburgh now have easier access to the robotic-assisted total-hip ... Allegheny Health Network (AHN). Orthopaedic surgeons at Forbes Hospital and Jefferson Hospital ...
Breaking Medicine News(10 mins):